Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability

Number of employees rises by 30 percent to nearly 14,000

27-Jan-2022 - Due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions, the life science group Sartorius closed fiscal 2021 with exceptionally strong growth and a jump in profitability. According to preliminary figures, the company ...

WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis

Expansion of WACKER's portfolio as a contract manufacturer for the pharmaceutical industry

04-Feb-2021 - The Munich-based chemical company WACKER is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis Inc. from Helixmith Co Ltd, Seoul (South Korea) and Medivate Partners LLC, Seoul (South Korea). WACKER signed a corresponding agreement. WACKER will continue Genopis' ...

Eurofins to acquire EAG Laboratories

Expanding its presence in North America

20-Sep-2017 - Eurofins Scientific announces that it has signed an agreement to acquire EAG Laboratories, a scientific services company providing analytical testing and consulting solutions to a diverse and demanding set of end markets, from Odyssey Investment Partners. The transaction is expected to close in ...

Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

23-Sep-2014 - Merck and Sigma-Aldrich announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will acquire all of the outstanding ...

IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually through 2014

Peak years of patent expiries shift growth toward generics

23-Apr-2010 - IMS Health reported that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion (ex manufacturer prices) over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading ...

Biomanufacturing Symposium at BIOTECHNICA 2009

Collaboration of drug developers and manufacturers

22-Sep-2009 - The second edition of this year’s Biomanufacturing Symposium on 7th October 2009 at BIOTECHNICA in Hannover (Germany), offers an ideal exchange platform for biopharma drug developers and manufacturers. This one-day event jointly organised by Capgemini Consulting and Deutsche Messe will address ...

CMC Acquires Former ICOS Biologics Operation in Bothell, Washington State, USA

CMC Biopharmaceuticals to purchase facility from Lilly; will retain existing employees

05-Dec-2007 - CMC Biopharmaceuticals A/S (CMC) announced that it has reached an agreement to buy the biologics development and manufacturing operation that Eli Lilly and Company acquired when it purchased ICOS Corporation in January 2007. CMC, a Copenhagen based leading provider of contract biomanufacturing ...

UK consortium led by Paraytec Ltd to develop analytical instrumentation to detect aggregation in biopharmaceutical processing

04-Dec-2007 - A multi-disciplinary UK consortium of partners including Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford has recently been awarded research grants by the Technology Strategy Board and the Engineering and Physical Sciences Research Council. The part funded £1M+ project is to ...

Beiersdorf affiliate Nivea Seoul Ltd. enters alliance for product distribution in Korean wound healing market

07-Jul-2006 - NIVEA Seoul Ltd., the Korean affiliate of Beiersdorf, entered a strategic alliance with Green Cross Corporate (GCC). The contract signing ceremony for Hansaplast distribution took place in June. The alliance aims to build a business platform for the launch of plasters in 2007. In Korea, the ...

SGS Opens Up New Contract Analytical Laboratory for Quality Control Testing in Singapore

08-Mar-2006 - SGS celebrated the opening of its new laboratory dedicated to Quality Control testing of pharmaceuticals, biopharmaceuticals and medical devices. This laboratory expands SGS' Life Science Services business international network of currently 16 pharmaceutical Quality Control (QC) operations in ...